Search research articles
Contact Us
Filters
Showing results (31-40 of 768) with videos related to
Page
of 77
Sort By:
Radiation Protection Dosimetry
|
April 29, 2006
The MATROSHKA facility--dose determination during an EVA
Guenther Reitz, Thomas Berger
The New England Journal of Medicine
|
October 21, 2005
Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis
Thomas Berger, Florian Deisenhammer
Psychotherapie, Psychosomatik, Medizinische Psychologie
|
April 7, 2009
[Internet-based psychotherapies: characteristics and empirical evidence]
Thomas Berger, Gerhard Andersson
The European Journal of Neuroscience
|
June 8, 2011
Persistent activity in layer 5 pyramidal neurons following cholinergic activation of mouse primary cortices
Jamilur Rahman, Thomas Berger
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 8, 2020
Commentary on "Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis"
Gabriel Bsteh, Thomas Berger
Frontiers in Chemistry
|
December 3, 2021
Impact of Nanoparticle Consolidation on Charge Separation Efficiency in Anatase TiO<sub>2</sub> Films
Karin Rettenmaier, Thomas Berger
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 22, 2022
Reply to letter to the editor: Olfactory threshold as a biomarker of disease activity
Gabriel Bsteh, Thomas Berger
Scientific Reports
|
July 16, 2025
Gyroid as a novel approach to suppress vortex shedding and mitigate induced vibration
Thomas Berger, Mohamed Farhat
Experiments in Fluids
|
May 26, 2026
Gyroid porous inserts as a novel flow control to mitigate tip vortex cavitation
Thomas Berger, Mohamed Farhat
JMIR Formative Research
|
December 16, 2024
Participant Adherence and Contact Behavior in a Guided Internet Intervention for Depressive Symptoms: Exploratory Study
Oliver Thomas Bur, Thomas Berger
Page
of 77
Search research articles
Search
Showing results (31-40 of 768) with videos related to
Sort By:
Page
of 77
Radiation Protection Dosimetry
|
April 29, 2006
The MATROSHKA facility--dose determination during an EVA
Guenther Reitz, Thomas Berger
The New England Journal of Medicine
|
October 21, 2005
Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis
Thomas Berger, Florian Deisenhammer
Psychotherapie, Psychosomatik, Medizinische Psychologie
|
April 7, 2009
[Internet-based psychotherapies: characteristics and empirical evidence]
Thomas Berger, Gerhard Andersson
The European Journal of Neuroscience
|
June 8, 2011
Persistent activity in layer 5 pyramidal neurons following cholinergic activation of mouse primary cortices
Jamilur Rahman, Thomas Berger
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 8, 2020
Commentary on "Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis"
Gabriel Bsteh, Thomas Berger
Frontiers in Chemistry
|
December 3, 2021
Impact of Nanoparticle Consolidation on Charge Separation Efficiency in Anatase TiO<sub>2</sub> Films
Karin Rettenmaier, Thomas Berger
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 22, 2022
Reply to letter to the editor: Olfactory threshold as a biomarker of disease activity
Gabriel Bsteh, Thomas Berger
Scientific Reports
|
July 16, 2025
Gyroid as a novel approach to suppress vortex shedding and mitigate induced vibration
Thomas Berger, Mohamed Farhat
Experiments in Fluids
|
May 26, 2026
Gyroid porous inserts as a novel flow control to mitigate tip vortex cavitation
Thomas Berger, Mohamed Farhat
JMIR Formative Research
|
December 16, 2024
Participant Adherence and Contact Behavior in a Guided Internet Intervention for Depressive Symptoms: Exploratory Study
Oliver Thomas Bur, Thomas Berger
Page
of 77